When is the Dyspnea Worth It? Understanding Functional Performance in People with Alpha-1 Antitrypsin Deficiency

Journal of Nursing Scholarship

Volumn 30, Issue 4, 1998, Pages 339-343

  Knebel, Ann ^a   Leidy, Nancy Kline ^b   Sherman, Sandra ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Functional health patterns; Model building, activities of daily living; Quality of life; Response to disease illness

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CONTROL; DAILY LIFE ACTIVITY; DECISION MAKING; DYSPNEA; EMPHYSEMA; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MOTIVATION; NURSING METHODOLOGY RESEARCH; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHOICE BEHAVIOR; DYSPNEA; EMPHYSEMA; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; MIDDLE AGED; MOTIVATION; NURSING METHODOLOGY RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0032246805     PISSN: 15276546     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1547-5069.1998.tb01330.x     Document Type: Article

References (24)

1. American Thoracic Society. (1989). Guidelines for the approach to the patient with severe hereditary alpha-1 antitrypsin deficiency. American Review of Respiratory Disease, 40, 1494-1497.
2. Bengali, Z. (1989). Inherited deliciency of alpha-1 antitrypsin and emphysema. Prospects and promise of research. Cleveland Clinic Journal of Medicine, 56, 671-674.
3. Blank, C.A., & Brantly, M. (1994). Clinical features and molecular characteristics of alpha-1 antitrypsin deficiency. Annals of Allergy, 72, 105-122.
4. Brantly, M., Paul, L., Miller, B., Falk, R., Wu, M., & Crystal, R. (1988). Clinical features and history of the destructive lung disease associated with alpha-1 antitrypsin deficiency of adults with pulmonary symptoms. American Review of Respiratory Disease, 138, 327-336.
5. Celli, B. (1995). Pulmonary rehabilitation in patients with COPD. American Journal of Respiratory and Critical Care Medicine, 52, 861-864.
6. Folden, S. (1993). Definitions of health and health goals of participants in a community-based pulmonary rehabilitation program Public Health Nursing, 10, 31-35.
7. Geddes, D.M., & Beckles, M.A. (1995). Gene therapy for alpha-1 antitrypsin deficiency. Monaldi Archives of Chest Disease, 50(5), 388-393.
8. Graydon, J.E., Ross, R., Webster, P.M., Goldstein, R.S., & Avendano, M. (1995). Predictors of functioning of patients with chronic obstructive pulmonary disease. Heart and Lung, 24, 369-375.
9. Guyatt, G., Berman, L., Townsend, M., Pugsley, S., & Chambers, L. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42, 773-778.
10. Guyatt, G., Townsend, M., Berman, L., & Pugsley, S. (1987). Quality of life in patients with chronic airflow limitation. British Journal of Diseases of the Chest, 81, 45-54.
11. Juniper, E., Guyatt, G., Epstein, R., Ferrie, P., Jaeschke, R., & Hiller, T. (1992). Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax, 47, 76-83.
12. Leidy, N.K., & Haase, J. (1996a). Functional performance in people with chronic obstructive pulmonary disease: a qualitative analysis. Advances in Nursing Science, 18, 77-89.
13. Leidy, N.K., & Haase, J. (1996b). Preserving personal integrity in the face of chronic illness: A qualitative study of functional performance in people with COPD. Research in Nursing and Health, (in press).
14. Leidy, N.K., & Traver, G. (1995). Psychophysiologic factors contributing to functional performance in people with COPD: Are there gender differences? Research in Nursing and Health, 18, 535-546.
15. MacDonald, J.L., & Johnson, C.E. (1995). Pathophysiology and treatment of alpha-1 anttrypsin deficiency. American Journal of Health System Pharmacists, 52, 481-489.
16. McElvaney, N.G., Stoller, J.K., Buist, A.S., Prakash, U.B.S., Brantly, M.L., Schluchter, M.D., Crystal, R.D., & the Alpha-1 Antitrypsin Deficiency Registry Study Group. (1997). Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute registry of alpha-1 antitrypsin deficiency. Chest, 111, 394-403.
17. Seersflolm, N., Kok-Jensen, A., & Dirksen, A. (1994). Survival of patients with severe alpha-1 antitrypsin deficiency with special reference to nonindex cases. Thorax, 94, 695-698.
18. Sherman, S., Brown, B., Wallace, S., Sachs, G., & Knebel, A. (1995). Severity of illness and quality of life in alpha-1 antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine, 151, A656.
19. Silverman, E., Pierce, J., Province, M., Rao, D., & Campbell, E. (1989). Variability of pulmonary function in alpha-1 antitrypsin deficiency: Clinical correlates. Annals of Internal Medicine, 111, 982-991.
20. Stoller, J. (1989). Alpha-1 antitrypsin deficiency and augmentation therapy in emphysema. Cleveland Clinic Journal of Medicine, 56, 683-689.
21. Stoller, J., Smith, P., Yang, P., & Spray, J. (1994). Physical and social impact of alpha-1 antitrypsin deficiency: Results of a survey. Cleveland Clinic Journal of Medicine, 61, 461-467.
22. van Steenbergen, W. (1993). Alpha-1 antitrypsin deficiency: An overview. ACTA Clinica Belgica, 48(3), 171-189.
23. Weaver, T.E., Richmond, T.S., & Narsavage, G.L. (1997). An explanatory model of functional status in chronic obstructive pulmonary disease. Nursing Research, 46, 26-31.
24. World Health Organization. (1997). Alpha-1 antitrypsin deficiency: Memorandum from a WHO meeting. Bulletin of the World Health Organization, 75(5), 397-415.